[Immunosuppression in organ transplantation].
D000818:Animals; D000906:Antibodies; D000961:Antilymphocyte Serum; D003520:Cyclophosphamide / Q000494:pharmacology; D003609:Dactinomycin / Q000494:pharmacology; D005112:Extracorporeal Circulation; D005493:Folic Acid Antagonists / Q000494:pharmacology; D005938:Glucocorticoids / Q000494:pharmacology; D006084:Graft Rejection; D006649:Histocompatibility Antigens; D006650:Histocompatibility Testing; D006801:Humans; D007165:Immunosuppression Therapy; D007166:Immunosuppressive Agents / Q000494:pharmacology; D007962:Leukocytes / Q000276:immunology; D008212:Lymphocyte Depletion; D051379:Mice; D014019:Tissue Donors; D014181:Transplantation Immunology / Q000187:drug effects
D000906:Antibodies; D000961:Antilymphocyte Serum; D005493:Folic Acid Antagonists; D005938:Glucocorticoids; D006649:Histocompatibility Antigens; D007166:Immunosuppressive Agents; D003609:Dactinomycin; D003520:Cyclophosphamide
Immunsuppression bei Organverpflanzung.